首页> 外国专利> ANSIOLITIC AGENTS WITH REDUCED SEDANTS AND ATAXIC SECONDARY EFFECTS.

ANSIOLITIC AGENTS WITH REDUCED SEDANTS AND ATAXIC SECONDARY EFFECTS.

机译:具有减少的边际和ATAXIA次要作用的抗焦虑剂。

摘要

Compound of formula I or a salt or prodrug thereof, (See formula) in which: Y and Z are considered together with the two carbon atoms involved to form a ring selected from phenyl and thienyl, whose ring is substituted in the C (8) position with at least the substituent -C = CR, where R is H, Si (CH3) 3, t-butyl, isopropyl, methyl or cyclopropyl; R2 is a cyclic or heterocyclic ring of 5 or 6 links substituted or unsubstituted at least partially unsaturated, in which if the substituent is substituted it is one or more of F, Cl, Br or NO2 in the 2 '' position; and R10 is (See formula) in which n is from 0 to 4, (See formula) in which n is 1 or 2, in which (See formula) Y '' and Z '' are considered together with the two carbon atoms that intervene to form a ring selected from phenyl and thienyl, whose ring is substituted at the C (8) '' position with at least the substituent -C = CR, where R '' H, Si (CH3) 3, t-butyl, isopropyl, methyl or cyclopropyl; R5 is a halogenated or non-halogenated C1 to C4 straight or branched chain alkyl or a methylcyclopropyl; R6 is a C1 to C4 branched or straight chain alkyl or a methyl cyclopropyl; R1 '' is one of H, CH3, CF3, CH2CF3, CH2CH3 or cyclopropyl; R2 '' is a cyclic or heterocyclic ring of 5 or 6 links substituted or unsubstituted at least partially unsaturated, in which if the substituent is substituted it is one or more of F, Cl, Br or NO2 in position 2 '' ; and wherein when R10 is C-CO2-R5, R1 is one of H, CH3, CF3, CH2CF3, CH2CH3, CH2C = CH, an alkyl or cyclopropyl; but, R1 is one of H, CH3, CF3, CH2CH3, CH2CF3 or cyclopropyl; and in which (See formula) when R10 is, (See formula) B is O or NH and in which -BCH2B- is optionally substituted with -N (R7) -N (R7), in which R7 is one of between H, CH3, alkyl or cycloalkyl; and when R 10 is (See formula) B is O, NH or -N (R 7) -N (R 7) -, wherein R 7 is one of H, CH 3, alkyl or cycloalkyl.
机译:式I的化合物或其盐或前药(参见式),其中:Y和Z与所涉及的两个碳原子一起形成选自苯基和噻吩基的环,其环被C取代(8)至少具有取代基-C = CR的位置,其中R为H,Si(CH 3)3,叔丁基,异丙基,甲基或环丙基; R2是5或6个被取代或未取代的至少部分不饱和的键的环或杂环,其中如果取代基被取代,则其为在2''位置的一个或多个F,Cl,Br或NO2; R10为(参见式),其中n为0至4,(参见式),其中n为1或2,其中(参见式)Y''和Z''与两个碳原子一起考虑插入形成选自苯基和噻吩基的环,其环在C(8)''位置至少被取代基-C = CR取代,其中R''H,Si(CH3)3,叔丁基,异丙基,甲基或环丙基; R5是卤代或非卤代的C1-C4直链或支链烷基或甲基环丙基; R6为C1至C4的支链或直链烷基或甲基环丙基; R1''为H,CH3,CF3,CH2CF3,CH2CH3或环丙基中的一种; R 2”是5或6个被取代或未取代的至少部分不饱和的键的环状或杂环,其中如果取代基被取代,则其为位置2”中的F,Cl,Br或NO 2中的一个或多个。其中R10为C-CO2-R5时,R1为H,CH3,CF3,CH2CF3,CH2CH3,CH2C = CH中的一种,为烷基或环丙基;但是,R1是H,CH3,CF3,CH2CH3,CH2CF3或环丙基之一;并且其中当R10为时(参见式),(B)为O或NH,并且其中-BCH2B-任选地被-N(R7)-N(R7)取代,其中R7为H之间的一个, CH 3,烷基或环烷基;当R 10为(见式)时,B为O,NH或-N(R 7)-N(R 7)-,其中R 7为H,CH 3,烷基或环烷基之一。

著录项

  • 公开/公告号ES2300576T3

    专利类型

  • 公开/公告日2008-06-16

    原文格式PDF

  • 申请/专利权人 WISYS TECHNOLOGY FOUNDATION INC.;

    申请/专利号ES20030723846T

  • 申请日2003-03-28

  • 分类号C07D243/14;A61K31/551;A61K31/5513;A61K31/5517;A61P1/08;A61P25;A61P25/18;A61P25/22;C07D243/12;C07D243/18;C07D243/20;C07D243/24;C07D401/04;C07D417/04;C07D471/04;C07D487/04;C07D487/06;C07D495/04;C07D495/14;C07D498/04;C07D519;

  • 国家 ES

  • 入库时间 2022-08-21 20:04:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号